-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
- KalVista Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending January 31, 2024 was 34.7 M shares, a 22.8% increase year-over-year.
- KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 27.9 M shares, a 14% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 24.5 M shares, a 28.2% increase from 2020.
- KalVista Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 19.1 M shares, a 7.58% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)